105 related articles for article (PubMed ID: 21544078)
1. A phase I study evaluating tolerability, pharmacokinetics, and preliminary efficacy of L-menthol in upper gastrointestinal endoscopy.
Hiki N; Kaminishi M; Hasunuma T; Nakamura M; Nomura S; Yahagi N; Tajiri H; Suzuki H
Clin Pharmacol Ther; 2011 Aug; 90(2):221-8. PubMed ID: 21544078
[TBL] [Abstract][Full Text] [Related]
2. Multicenter phase II randomized study evaluating dose-response of antiperistaltic effect of L-menthol sprayed onto the gastric mucosa for upper gastrointestinal endoscopy.
Hiki N; Kaminishi M; Yasuda K; Uedo N; Kobari M; Sakai T; Hiratsuka T; Ohno K; Honjo H; Nomura S; Yahagi N; Tajiri H; Suzuki H
Dig Endosc; 2012 Mar; 24(2):79-86. PubMed ID: 22348831
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology and preclinical pharmacokinetics of peppermint oil.
Grigoleit HG; Grigoleit P
Phytomedicine; 2005 Aug; 12(8):612-6. PubMed ID: 16121523
[TBL] [Abstract][Full Text] [Related]
4. Antiperistaltic effect and safety of L-menthol sprayed on the gastric mucosa for upper GI endoscopy: a phase III, multicenter, randomized, double-blind, placebo-controlled study.
Hiki N; Kaminishi M; Yasuda K; Uedo N; Honjo H; Matsuhashi N; Hiratsuka T; Sekine C; Nomura S; Yahagi N; Tajiri H; Suzuki H
Gastrointest Endosc; 2011 May; 73(5):932-41. PubMed ID: 21353674
[TBL] [Abstract][Full Text] [Related]
5. Metabolic fate of [3H]-l-menthol in the rat.
Yamaguchi T; Caldwell J; Farmer PB
Drug Metab Dispos; 1994; 22(4):616-24. PubMed ID: 7956738
[TBL] [Abstract][Full Text] [Related]
6. An open-label, single-arm study assessing the efficacy and safety of L: -menthol sprayed onto the gastric mucosa during upper gastrointestinal endoscopy.
Hiki N; Kaminishi M; Tanabe S; Fujisaki J; Yoshino J; Iguchi M; Kobayashi H; Ashida K; Kawabe T; Kawano T; Nomura S; Yahagi N; Tajiri H; Suzuki H
J Gastroenterol; 2011 Jul; 46(7):873-82. PubMed ID: 21559772
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of spraying l-menthol solution during endoscopic treatment of early gastric cancer: a phase III, multicenter, randomized, double-blind, placebo-controlled study.
Fujishiro M; Kaminishi M; Hiki N; Oda I; Fujisaki J; Uedo N; Kaise M; Tanabe S; Iguchi M; Matsuhashi N; Nomura S; Tajiri H; Yahagi N; Suzuki H
J Gastroenterol; 2014 Mar; 49(3):446-54. PubMed ID: 23800946
[TBL] [Abstract][Full Text] [Related]
8. A Novel Ileocolonic Release Peppermint Oil Capsule for Treatment of Irritable Bowel Syndrome: A Phase I Study in Healthy Volunteers.
Weerts ZZRM; Keszthelyi D; Vork L; Aendekerk NCP; Frijlink HW; Brouwers JRBJ; Neef C; Jonkers DMAE; Masclee AAM
Adv Ther; 2018 Nov; 35(11):1965-1978. PubMed ID: 30284674
[TBL] [Abstract][Full Text] [Related]
9. L-Menthol for Gastrointestinal Endoscopy: A Systematic Review and Meta-Analysis.
You Q; Li L; Chen H; Chen L; Chen X; Liu Y
Clin Transl Gastroenterol; 2020 Oct; 11(10):e00252. PubMed ID: 33031198
[TBL] [Abstract][Full Text] [Related]
10. Antiperistaltic effect and safety of l-menthol oral solution on gastric mucosa for upper gastrointestinal endoscopy in Chinese patients: Phase III, multicenter, randomized, double-blind, placebo-controlled study.
Meng F; Li W; Zhi F; Li Z; Xue Z; He S; Chen W; Chen Y; Xing X; Yao C; Wu Y; Zhang S
Dig Endosc; 2021 Nov; 33(7):1110-1119. PubMed ID: 33527576
[TBL] [Abstract][Full Text] [Related]
11. Partial characterization of biliary metabolites of pulegone by tandem mass spectrometry. Detection of glucuronide, glutathione, and glutathionyl glucuronide conjugates.
Thomassen D; Pearson PG; Slattery JT; Nelson SD
Drug Metab Dispos; 1991; 19(5):997-1003. PubMed ID: 1686249
[TBL] [Abstract][Full Text] [Related]
12. The inhibition of bone resorption in rats treated with (-)-menthol is due to its metabolites.
Spichiger M; Brenneisen R; Felix R; Mühlbauer RC
Planta Med; 2006 Nov; 72(14):1290-5. PubMed ID: 17021997
[TBL] [Abstract][Full Text] [Related]
13. Disposition kinetics and effects of menthol.
Gelal A; Jacob P; Yu L; Benowitz NL
Clin Pharmacol Ther; 1999 Aug; 66(2):128-35. PubMed ID: 10460066
[TBL] [Abstract][Full Text] [Related]
14. Determination of menthol and menthol glucuronide in human urine by gas chromatography using an enzyme-sensitive internal standard and flame ionization detection.
Kaffenberger RM; Doyle MJ
J Chromatogr; 1990 Apr; 527(1):59-66. PubMed ID: 2365793
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
16. Menthol-beta-D-glucuronide: a potential prodrug for treatment of the irritable bowel syndrome.
Nolen HW; Friend DR
Pharm Res; 1994 Dec; 11(12):1707-11. PubMed ID: 7899232
[TBL] [Abstract][Full Text] [Related]
17. Two single-center, double-blind, randomized, placebo-controlled, phase I studies to investigate the tolerability and pharmacokinetics of CH-1504, an antifolate, in healthy male subjects.
Mant T; Jurcevic S; Szakacs C; Adams L; Boland J; Hewitt LA
Clin Ther; 2008 Jan; 30(1):131-42. PubMed ID: 18343249
[TBL] [Abstract][Full Text] [Related]
18. Simple measurement of gluconeogenesis by direct 2H NMR analysis of menthol glucuronide enrichment from 2H2O.
Ribeiro A; Caldeira MM; Carvalheiro M; Bastos M; Baptista C; Fagulha A; Barros L; Barosa C; Jones JG
Magn Reson Med; 2005 Aug; 54(2):429-34. PubMed ID: 16032678
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and metabolism of nateglinide in humans.
Weaver ML; Orwig BA; Rodriguez LC; Graham ED; Chin JA; Shapiro MJ; McLeod JF; Mangold JB
Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):415-21. PubMed ID: 11259325
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, pharmacodynamics, and tolerability of the dipeptidyl peptidase IV inhibitor LC15-0444 in healthy Korean men: a dose-block-randomized, double-blind, placebo-controlled, ascending single-dose, Phase I study.
Lim KS; Kim JR; Choi YJ; Shin KH; Kim KP; Hong JH; Cho JY; Shin HS; Yu KS; Shin SG; Kwon OH; Hwang DM; Kim JA; Jang IJ
Clin Ther; 2008 Oct; 30(10):1817-30. PubMed ID: 19014837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
